Internal Medicine, Cardiovascular Disease · Austin, TX
NPI
1518065317
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
2608 Brockton Dr
Austin, TX, 78758
Phone (512) 654-4050
Groups this clinician bills Medicare through
Medicare paid, 2024
$271K
5,575 services
Medicare patients, 2024
776
Average age 75
Drug cost, 2024
$2.1M
13,725 prescriptions
Company payments, 2025
$413
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fotini M Chalkias was code 99214 (office e&m - established), 1,876 times for 728 patients. In total Fotini M Chalkias billed 5,575 services in 29 codes, and Medicare paid $271K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,876 | 728 | $82.21 | $154K |
| 93000 Electrocardiogram | Office | 904 | 613 | $9.49 | $8,579 |
| 93005 Electrocardiogram | Office | 904 | 617 | $4.07 | $3,677 |
| 93306 Echocardiography (TTE/TEE) | Office | 480 | 474 | $121.81 | $58K |
| 36415 Venipuncture Blood Collection | Office | 246 | 198 | $8.62 | $2,120 |
| 93016 Electrocardiogram | Office | 183 | 181 | $13.58 | $2,485 |
| 93018 Electrocardiogram | Office | 183 | 181 | $9.15 | $1,675 |
| 78452 Myocardial Perfusion Scan | Office | 173 | 173 | $48.44 | $8,380 |
| Q9957 Injection, perflutren lipid microspheres, per ml | Office | 162 | 81 | $32.36 | $5,243 |
| 99204 Office E&M - New | Office | 116 | 116 | $107.14 | $12K |
| 93248 Electrocardiogram | Facility | 93 | 86 | $17.23 | $1,602 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 52 | 52 | $133.59 | $6,947 |
| 93356 Echocardiography (TTE/TEE) | Office | 40 | 39 | $26.22 | $1,049 |
| 93306 Echocardiography (TTE/TEE) | Facility | 31 | 31 | $39.41 | $1,222 |
| 93010 Electrocardiogram | Office | 29 | 28 | $5.33 | $155 |
By year: 2022 $555K for 6,745 services; 2023 $338K for 5,935 services; 2024 $271K for 5,575 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 246 | 198 | $8.62 | $2,120 |
Medicare prescription drug claims, 2024
In 2024, the drug Fotini M Chalkias prescribed most often to Medicare patients was Metoprolol Succinate, with 1,525 prescriptions and refills. In total Fotini M Chalkias wrote 13,725 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,525 | 3,820 | 418 | $22K |
| Rosuvastatin Calcium Generic | 938 | 2,659 | 294 | $14K |
| Flecainide Acetate Generic | 754 | 1,654 | 210 | $24K |
| Xarelto Rivaroxaban | 711 | 1,317 | 153 | $682K |
| Amlodipine Besylate Generic | 697 | 1,752 | 216 | $3,857 |
| Atorvastatin Calcium Generic | 669 | 1,913 | 207 | $5,259 |
| Eliquis Apixaban | 604 | 1,032 | 129 | $573K |
| Spironolactone Generic | 484 | 1,145 | 151 | $3,680 |
| Losartan Potassium Generic | 410 | 1,081 | 132 | $4,477 |
| Carvedilol Generic | 389 | 1,050 | 111 | $4,158 |
| Furosemide Generic | 388 | 861 | 147 | $1,912 |
| Lisinopril Generic | 327 | 901 | 96 | $2,660 |
| Olmesartan Medoxomil Generic | 310 | 816 | 92 | $6,236 |
| Clonidine Hcl Generic | 299 | 739 | 98 | $2,595 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 271 | 698 | 83 | $7,985 |
Brand drugs: 2,101 claims; generic drugs: 11,624 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fotini M Chalkias $413 ($413 in general payments such as food, travel and fees) from 11 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $91.65.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $91.65 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $53.96 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $50.12 |
| Vital Connect, Inc | 2 | $47.37 |
| Novo Nordisk Inc NVO | 2 | $40.45 |
| Edwards Lifesciences Corporation EW | 1 | $35.6 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.1 |
| Dexcom, Inc. DXCM | 1 | $19 |
| Merck Sharp & Dohme LLC MRK | 1 | $17.09 |
| Amgen Inc. AMGN | 1 | $17.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.